Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

roche.com

Investor Update

Get the latest updates from Investor Update directly as they happen.

Follow now 341 followers

Latest posts

Last updated 1 day ago

Reminder: Invitation to Roche’s Virtual Neurology Investor Event

1 day ago

We are pleased to invite investors and analysts to participate in our...

Roche Annual General Meeting 2025

4 days ago

Shareholders approved all proposals of the Board of Directors Severin Schwan was...

Invitation to Roche’s First Quarter Sales 2025 Presentation

5 days ago

Roche will publish its Sales Results for the 1st Quarter 2025 prior...

Roche to share latest scientific advancements from its neuromuscular portfolio at Muscular Dystrophy Association (MDA) 2025 conference

12 days ago

New Evrysdi five-year data from the SUNFISH study showed continued stabilisation of...

FDA accepts supplemental Biologics License Application for Roche’s Gazyva/Gazyvaro for the treatment of lupus nephritis

24 days ago

Gazyva/Gazyvaro is the only anti-CD20 monoclonal antibody in a randomised phase III...

Invitation to Roche’s Virtual Neurology Investor Event

25 days ago

  We are pleased to invite investors and analysts to participate in our...

Phase III study shows Xolair may be more effective with fewer side effects than oral immunotherapy for the treatment of food allergies

27 days ago

First-ever head-to-head trial comparing Xolair and oral immunotherapy (OIT) Results were featured...

Roche unveils a new class of next-generation sequencing with its novel sequencing by expansion technology

about 1 month ago

Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in...

Reminder: Invitation to Roche’s Virtual Event on the SBX (sequencing by expansion) technology

about 1 month ago

We are pleased to invite investors and analysts to participate in our...

Invitation to Roche’s Virtual Event on the SBX (sequencing by expansion) technology

about 2 months ago

  We are pleased to invite investors and analysts to participate in our...